Back

Is natriuretic peptide effective in screening for subclinical heart failure among cancer survivors?

30 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Heart failure pathways: natriuretic peptides and microvascular inflammation Biomarkers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Cheng Hwee Soh

Baker Heart and Diabetes Institute, Melbourne (Australia)

7 More presentations in this session

Presentation thumbnail
Sex-specific diagnostic and prognostic value of a resting biventricular myocardial blood flow ratio measured by PET in chronic coronary syndromes
Mr P. Svanstrom (Uppsala, SE)
Abstract Slides Video
Presentation thumbnail
Pre-randomization NT-proBNP trajectory and outcomes in the VICTOR trial
Professor J. Butler (Dallas, US)
Abstract Slides Video
Presentation thumbnail
Sex-specific phenotypes, biomarkers, and outcomes in chronic heart failure: insights from a contemporary cohort of women
Doctor D. Abidova (Tashkent, UZ)
Abstract Slides
Presentation thumbnail
Prognostic impact of microvascular dysfunction and systemic inflammation in women with chronic heart failure
Doctor D. Abidova (Tashkent, UZ)
Abstract Slides
Presentation thumbnail
Androgen metabolism and heart failure risk: sex-specific associations with NT-proBNP in a population-based cohort
Mr C. Evers (Greifswald, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure pathways: natriuretic peptides and microvascular inflammation

The Event

Event poster

ESC Congress 2026

30 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Cancer survivorship - heart failure risk factor or potentiator?
1 September 2024
thumbnail
Congress Presentation
Feasibility and outcomes of an automated high-alert NT-proBNP pathway
30 August 2026
thumbnail
Congress Presentation
Screening tools for heart failure in high-risk populations
10 May 2026
thumbnail
Congress Presentation
Clinical characteristics, resource use, and diagnostic accuracy of natriuretic peptides in cancer patients presenting with acute dyspnea to the Emergency Department
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources